{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:33:24Z","timestamp":1769826804116,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T00:00:00Z","timestamp":1601596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.exer.2020.108274","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T18:11:26Z","timestamp":1601662286000},"page":"108274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Intravitreal administration of small molecule read-through agents demonstrate functional activity in a nonsense mutation mouse model"],"prefix":"10.1016","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0169-8645","authenticated-orcid":false,"given":"Daniel K.","family":"Crawford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Vanlandingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1921-2615","authenticated-orcid":false,"given":"Susan","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6346-7220","authenticated-orcid":false,"given":"Matthew M.","family":"Goddeeris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 12","key":"10.1016\/j.exer.2020.108274_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/IAE.0000000000000399","article-title":"Intravitreal injection technique and monitoring: updated guidelines of an expert panel","volume":"34","author":"Avery","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.exer.2020.108274_bib2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/15476286.2017.1285480","article-title":"Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells","volume":"14","author":"Bidou","year":"2017","journal-title":"RNA Biol."},{"key":"10.1016\/j.exer.2020.108274_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223954","article-title":"The novel aminoglycoside, ELX-02, permits CTNSW138X translational read-through and restores lysosomal cystine efflux in cystinosis","volume":"14","author":"Brasell","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.exer.2020.108274_bib4","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1001\/archopht.1990.01070140094037","article-title":"Retinal toxicity of intravitreal gentamicin","volume":"108","author":"Brown","year":"1990","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108274_bib5","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1093\/nar\/13.17.6265","article-title":"Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin","volume":"13","author":"Burke","year":"1985","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.exer.2020.108274_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.biochi.2014.10.027","article-title":"NMD: at the crossroads between translation termination and ribosome recycling","volume":"114","author":"Celik","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.exer.2020.108274_bib7","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1164\/ajrccm.163.7.2004001","article-title":"Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis","volume":"163","author":"Clancy","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.exer.2020.108274_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archopht.1989.01070010109037","article-title":"Gentamicin toxicity in the primate retina","volume":"107","author":"Conway","year":"1989","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108274_bib9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/jpet.120.265595","article-title":"ELX-02 generates protein via premature stop codon read-through without inducing native stop codon read-through proteins","volume":"374","author":"Crawford","year":"2020","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.exer.2020.108274_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s10020-018-0024-7","article-title":"Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons","volume":"24","author":"Dabrowski","year":"2018","journal-title":"Mol. Med."},{"key":"10.1016\/j.exer.2020.108274_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1006\/jmbi.1997.1551","article-title":"Paromomycin binding induces a local conformational change in the A-site of 16 S rRNA","volume":"277","author":"Fourmy","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.exer.2020.108274_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206158","article-title":"The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential","volume":"13","author":"Friesen","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.exer.2020.108274_bib13","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/hmg\/8.10.1893","article-title":"Nonsense-mediated mRNA decay in health and disease","volume":"8","author":"Frischmeyer","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.exer.2020.108274_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1750-1172-2-43","article-title":"Oculocutaneous albinism","volume":"2","author":"Gr\u00f8nskov","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.exer.2020.108274_bib15","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1167\/iovs.05-0604","article-title":"Acute aminoglycoside retinal toxicity in vivo and in vitro","volume":"46","author":"Hancock","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.108274_bib16","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1021\/jm3012992","article-title":"Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations","volume":"55","author":"Kandasamy","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exer.2020.108274_bib17","first-page":"984","article-title":"Safety, tolerability, and pharmacokinetics of single ascending doses of ELX-02, a potential treatment for genetic disorders caused by nonsense mutations","volume":"8","author":"Leubitz","year":"2019"},{"key":"10.1016\/j.exer.2020.108274_bib18","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1261\/rna.061051.117","article-title":"Avoidance of reporter assay distortions from fused dual reporters","volume":"23","author":"Loughran","year":"2017","journal-title":"RNA"},{"key":"10.1016\/j.exer.2020.108274_bib19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archopht.1974.03900060501015","article-title":"Intraocular injection of gentamicin. Single injection therapy of experimental bacterial endophthalmitis","volume":"91","author":"May","year":"1974","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108274_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mrrev.2014.05.001","article-title":"Nonsense-mediated decay in genetic disease: friend or foe?","volume":"762","author":"Miller","year":"2014","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"10.1016\/j.exer.2020.108274_bib21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0022-2836(86)90441-9","article-title":"Rapid chemical probing of conformation in 16 S ribosomal RNA and 30 S ribosomal subunits using primer extension","volume":"187","author":"Moazed","year":"1986","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.exer.2020.108274_bib22","series-title":"Intravitreal injection technique: a primer for ophthalmology residents and fellows","author":"Myers Provencher","year":"2015"},{"key":"10.1016\/j.exer.2020.108274_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40259-016-0157-6","article-title":"Targeting nonsense mutations in diseases with translational read-through-inducing drugs (TRIDs)","volume":"30","author":"Nagel-Wolfrum","year":"2016","journal-title":"BioDrugs"},{"key":"10.1016\/j.exer.2020.108274_bib24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S0952523814000194","article-title":"Translational read-through as an alternative approach for ocular gene therapy of retinal dystrophies caused by in-frame nonsense mutations","volume":"31","author":"Nagel-Wolfrum","year":"2014","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.exer.2020.108274_bib25","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1016\/j.bmcl.2006.09.013","article-title":"Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations","volume":"16","author":"Nudelman","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.exer.2020.108274_bib26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fncel.2017.00325","article-title":"Towards the prevention of aminoglycoside-related hearing loss","volume":"11","author":"O'Sullivan","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.exer.2020.108274_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000316695","article-title":"Retinal and ocular toxicity in ocular application of drugs and chemicals--part II: retinal toxicity of current and new drugs","volume":"44","author":"Penha","year":"2010","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.exer.2020.108274_bib28","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0076-6879(10)78021-6","article-title":"Aminoglycosides redesign strategies for improved antibiotics and compounds for treatment of human genetic diseases","volume":"478","author":"Pokrovskaya","year":"2010","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.exer.2020.108274_bib29","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/thx.2009.131532","article-title":"Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis","volume":"65","author":"Prayle","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.exer.2020.108274_bib30","doi-asserted-by":"crossref","first-page":"E10899","DOI":"10.1073\/pnas.1715501114","article-title":"Aminoglycoside interactions and impacts on the eukaryotic ribosome","volume":"114","author":"Prokhorova","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2020.108274_bib31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1039\/C8MD00001H","article-title":"Exploring eukaryotic versus prokaryotic ribosomal RNA recognition with aminoglycoside derivatives","volume":"9","author":"Sabbavarapu","year":"2018","journal-title":"Medchemcomm"},{"key":"10.1016\/j.exer.2020.108274_bib32","first-page":"2","article-title":"Dual-luciferase reporter assay: an advanced Co-reporter technology integrating firefly and Renilla luciferase assays","volume":"57","author":"Sherf","year":"1996","journal-title":"Promega Notes"},{"key":"10.1016\/j.exer.2020.108274_bib33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1538\/expanim.14-0075","article-title":"A nonsense nucleotide substitution in the oculocutaneous albinism II gene underlies the original pink-eyed dilution allele (Oca2(p)) in mice","volume":"64","author":"Shoji","year":"2015","journal-title":"Exp. Anim."},{"key":"10.1016\/j.exer.2020.108274_bib34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/hum.2015.030","article-title":"Gene therapy of inherited retinal degenerations: prospects and challenges","volume":"26","author":"Trapani","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.exer.2020.108274_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/genes10090654","article-title":"Molecular therapies for inherited retinal diseases-current standing, opportunities and challenges","volume":"10","author":"V\u00e1zquez-Dom\u00ednguez","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.exer.2020.108274_bib36","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJMoa022170","article-title":"Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations","volume":"349","author":"Wilschanski","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2020.108274_bib37","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1165\/rcmb.2013-0282OC","article-title":"Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor","volume":"50","author":"Xue","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.exer.2020.108274_bib38","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0002-9394(76)90549-3","article-title":"Experimental intravitreal gentamicin","volume":"82","author":"Zachary","year":"1976","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108274_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225722","article-title":"Gene therapy in retinal dystrophies","volume":"20","author":"Ziccardi","year":"2019","journal-title":"Int. J. Mol. Sci."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483520305327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483520305327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:06:48Z","timestamp":1757999208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483520305327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":39,"alternative-id":["S0014483520305327"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2020.108274","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal administration of small molecule read-through agents demonstrate functional activity in a nonsense mutation mouse model","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2020.108274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108274"}}